<VariationArchive VariationID="583293" VariationName="NM_006147.4(IRF6):c.1314_1324del (p.Gln438fs)" VariationType="Deletion" Accession="VCV000583293" Version="10" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2018-10-10" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="558343" VariationID="583293">
      <GeneList>
        <Gene Symbol="IRF6" FullName="interferon regulatory factor 6" GeneID="3664" HGNC_ID="HGNC:6121" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q32.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="209785617" stop="209806142" display_start="209785617" display_stop="209806142" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="209958967" stop="209979519" display_start="209958967" display_stop="209979519" Strand="-" />
          </Location>
          <OMIM>607199</OMIM>
          <Haploinsufficiency last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=IRF6">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=IRF6">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_006147.4(IRF6):c.1314_1324del (p.Gln438fs)</Name>
      <CanonicalSPDI>NC_000001.11:209788499:TGCGGTACAGCTGC:TGC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q32.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="209788500" stop="209788510" display_start="209788500" display_stop="209788510" variantLength="11" positionVCF="209788499" referenceAlleleVCF="ATGCGGTACAGC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="209961845" stop="209961855" display_start="209961845" display_stop="209961855" variantLength="11" positionVCF="209961844" referenceAlleleVCF="ATGCGGTACAGC" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>Q343fs</ProteinChange>
      <ProteinChange>Q438fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006147.3" sequenceAccession="NM_006147" sequenceVersion="3" change="c.1314_1324del">
            <Expression>NM_006147.3:c.1314_1324del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.209961848_209961858del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.209961848_209961858del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.209788503_209788513del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.209788503_209788513del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007081.2" sequenceAccession="NG_007081" sequenceVersion="2" change="g.22625_22635del">
            <Expression>NG_007081.2:g.22625_22635del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001206696.2" sequenceAccession="NM_001206696" sequenceVersion="2" change="c.1029_1039del">
            <Expression>NM_001206696.2:c.1029_1039del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001193625.1" sequenceAccession="NP_001193625" sequenceVersion="1" change="p.Gln343fs">
            <Expression>NP_001193625.1:p.Gln343fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006147.4" sequenceAccession="NM_006147" sequenceVersion="4" change="c.1314_1324del" MANESelect="true">
            <Expression>NM_006147.4:c.1314_1324del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006138.1" sequenceAccession="NP_006138" sequenceVersion="1" change="p.Gln438fs">
            <Expression>NP_006138.1:p.Gln438fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1558038218" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006147.4(IRF6):c.1314_1324del (p.Gln438fs) AND multiple conditions" Accession="RCV000707591" Version="10">
        <ClassifiedConditionList TraitSetID="65852">
          <ClassifiedCondition DB="MedGen" ID="C1837213">Orofacial cleft 6, susceptibility to</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0265259">Popliteal pterygium syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0175697">Van der Woude syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-05-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-05-23" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-10-10" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">19282774</ID>
        </Citation>
        <DescriptionHistory Dated="2020-07-15">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="65852" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="55926" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Lip pit syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Van der Woude syndrome</ElementValue>
                <XRef ID="Van+der+Woude+syndrome/7346" DB="Genetic Alliance" />
                <XRef ID="MONDO:0019508" DB="MONDO" />
                <XRef ID="79261008" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">VWS</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">LPS</ElementValue>
                <XRef Type="MIM" ID="119300" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">VDWS</ElementValue>
                <XRef Type="MIM" ID="119300" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PIT</ElementValue>
                <XRef Type="MIM" ID="119300" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8414" />
                <XRef ID="8414" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="888" DB="Orphanet" />
              <XRef ID="C0175697" DB="MedGen" />
              <XRef ID="MONDO:0019508" DB="MONDO" />
            </Trait>
            <Trait ID="3124" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 6</ElementValue>
                <XRef Type="MIM" ID="608864" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Orofacial cleft 6, susceptibility to</ElementValue>
                <XRef ID="Orofacial+cleft+6%2C+susceptibility+to/9044" DB="Genetic Alliance" />
                <XRef ID="MONDO:0012141" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OFC6</ElementValue>
                <XRef Type="MIM" ID="608864" DB="OMIM" />
              </Symbol>
              <XRef ID="C1837213" DB="MedGen" />
              <XRef ID="MONDO:0012141" DB="MONDO" />
              <XRef Type="MIM" ID="608864" DB="OMIM" />
            </Trait>
            <Trait ID="4007" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Popliteal pterygium syndrome</ElementValue>
                <XRef ID="Popliteal+pterygium+syndrome/5870" DB="Genetic Alliance" />
                <XRef ID="MONDO:0017435" DB="MONDO" />
                <XRef ID="66783006" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PPS</ElementValue>
                <XRef Type="MIM" ID="119500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Most commonly, IRF6-related disorders span a spectrum from isolated cleft lip and palate and Van der Woude syndrome (VWS) at the mild end to popliteal pterygium syndrome (PPS) at the more severe end. In rare instances, IRF6 pathogenic variants have also been reported in individuals with nonsyndromic orofacial cleft (18/3,811; 0.47%) and in individuals with spina bifida (2/192). Individuals with VWS show one or more of the following anomalies: Congenital, usually bilateral, paramedian lower-lip fistulae (pits) or sometimes small mounds with a sinus tract leading from a mucous gland of the lip. Cleft lip (CL). Cleft palate (CP). Note: Cleft lip with or without cleft palate (CL±P) is observed about twice as often as CP only. Submucous cleft palate (SMCP). The PPS phenotype includes the following: CL±P. Fistulae of the lower lip. Webbing of the skin extending from the ischial tuberosities to the heels. In males: bifid scrotum and cryptorchidism. In females: hypoplasia of the labia majora. Syndactyly of fingers and/or toes. Anomalies of the skin around the nails. A characteristic pyramidal fold of skin overlying the nail of the hallux (almost pathognomonic). In some nonclassic forms of PPS: filiform synechiae connecting the upper and lower jaws (syngnathia) or the upper and lower eyelids (ankyloblepharon). Other musculoskeletal anomalies may include spina bifida occulta, talipes equinovarus, digital reduction, bifid ribs, and short sternum. In VWS, PPS, IRF6-related neural tube defect, and IRF6-related orofacial cleft, growth and intelligence are typical.</Attribute>
                <XRef ID="NBK1407" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="21189" />
                <XRef ID="21189" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301581</ID>
                <ID Source="BookShelf">NBK1407</ID>
              </Citation>
              <XRef ID="294963" DB="Orphanet" />
              <XRef ID="C0265259" DB="MedGen" />
              <XRef ID="MONDO:0017435" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1608714" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2018-10-10">
        <ClinVarSubmissionID localKey="4221220|MedGen:C1837213;C0175697;C0265259" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000836692" DateUpdated="2024-02-28" DateCreated="2018-10-10" Type="SCV" Version="7" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-05-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19282774</ID>
          </Citation>
          <Comment>This variant has been observed to segregate with clinical features of van der Woude syndrome in a family (Invitae). This variant is not present in population databases (ExAC no frequency). This sequence change results in a frameshift in the IRF6 gene (p.Gln438Hisfs*61). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 29 amino acids of the IRF6 protein and extend the protein by an additional 32 amino acids. This variant results in an extension of the IRF6 protein. Other variant(s) that result in a similarly extended protein product (p.Ser457Glnfs*46, p.Met458Asnfs*45, and p.Ala463Serfs*40) have been observed in individuals with IRF6-related conditions (PMID: 19282774). These variants are also known as¬†p.Ser457GlnfsX43, p.Met458AsnfsX43, and Pro462_Ala463ArgfsX38, respectively, in the literature. This suggests that these extensions may be clinically significant. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="IRF6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.209961845_209961855del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1837213" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0175697" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0265259" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1608714" TraitType="Disease" MappingType="XRef" MappingValue="C0175697" MappingRef="MedGen">
        <MedGen CUI="C0175697" Name="Van der Woude syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1608714" TraitType="Disease" MappingType="XRef" MappingValue="C1837213" MappingRef="MedGen">
        <MedGen CUI="C1837213" Name="Orofacial cleft 6, susceptibility to" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1608714" TraitType="Disease" MappingType="XRef" MappingValue="C0265259" MappingRef="MedGen">
        <MedGen CUI="C0265259" Name="Popliteal pterygium syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

